AbbVie Inc.’s stock rose 5% early Friday to lead S&P 500 gainers premarket, after the drug company beat fourth-quarter earnings estimates and offered an upbeat view of 2025, as its newer immunology ...

Nothing says "I care about mental health" quite like sending people with psychiatric prescriptions to government farm camps ...

Prosecutor portrays a self-absorbed man trying to manipulate authorities to avoid criminal responsibility for his mother’s ...

It is well known that early intervention is key to helping people who experience mental ill health. The consequences of not ...

Significantly increased risk for tardive dyskinesia seen with doses >75 mg/day at last prescription and as maximum dose.

Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study published in JAMA Pediatrics. Montelukast is a leukotriene ...